ISSN 1301 - 0883 / E-ISSN 1309 - 3886
 
 








  The administration of low molecular weight heparin in severe case of covid-19, a case report [Eastern J Med]
Eastern J Med. 2020; 25(3): 461-464 | DOI: 10.5505/ejm.2020.92063  

The administration of low molecular weight heparin in severe case of covid-19, a case report

Ngakan Ketut Wira Suastika1, Ketut Suega2, Putu Utami Dewi1
1Udayana University Hospital, Bali, Indonesia
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Udayana University, Bali Indonesia

Coagulopathy and disseminated intravascular coagulation (DIC) is one of the complications of the corona virus disease 2019 (Covid-19) that can lead to death. Several studies have shown that anticoagulants provide good clinical outcomes in Covid-19 patients, especially in severe cases. This case emphasizes the administration of low molecular weight heparin (LMWH) to prevent venous thromboembolism (VTE) in severe case of Covid-19.

Keywords: Covid-19, coagulopathy, thromboembolism, anticoagulant


Ngakan Ketut Wira Suastika, Ketut Suega, Putu Utami Dewi. The administration of low molecular weight heparin in severe case of covid-19, a case report. Eastern J Med. 2020; 25(3): 461-464

Corresponding Author: Ngakan Ketut Wira Suastika, Indonesia


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
Copyright 2020 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale